PLX
Protalix BioTherapeutics, Inc.Company with tickers: PLX
Market Cap
$176.85M
Shares Outstanding
80,571,642
CIK
1006281
CUSIP
74365A309
13F Activity (30d)
2 filings
1 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-12-19 | Bashan Dror |
Director, PRESIDENT AND CEO | Buy | 56,000 |
| 2025-11-18 | Bar-Shalev Amos |
Director | Sell | 168 |
| 2025-09-03 | Bar-Shalev Amos |
Director | Award | 15,000 |
| 2025-09-03 | Boudes Pol F |
Director | Award | 15,000 |
| 2025-09-03 | Bar-Shalev Amos |
Director | Award | 7,500 |
| 2025-09-03 | Naos Yaron |
Sr. VP, Operations | Award | 50,000 |
| 2025-09-03 | Melincoff Gwen A |
Director | Award | 7,500 |
| 2025-09-03 | Forster Eliot |
Director | Award | 15,000 |
| 2025-09-03 | Schwartz Aharon |
Director | Award | 7,500 |
| 2025-09-03 | Ben Zvi Shmuel |
Director | Award | 15,000 |
| 2025-09-03 | Bashan Dror |
Director, PRESIDENT AND CEO | Award | 195,000 |
| 2025-09-03 | Bashan Dror |
Director, PRESIDENT AND CEO | Award | 340,000 |
| 2025-09-03 | Elze Christian |
Director | Award | 7,500 |
| 2025-09-03 | Forster Eliot |
Director | Award | 7,500 |
| 2025-09-03 | Naos Yaron |
Sr. VP, Operations | Award | 25,000 |
| 2025-09-03 | Melincoff Gwen A |
Director | Award | 15,000 |
| 2025-09-03 | Boudes Pol F |
Director | Award | 7,500 |
| 2025-09-03 | Elze Christian |
Director | Award | 15,000 |
| 2025-09-03 | Schwartz Aharon |
Director | Award | 15,000 |
| 2025-09-03 | Ben Zvi Shmuel |
Director | Award | 7,500 |
| 2025-06-26 | Elze Christian |
Director | Other | 0 |
| 2025-06-10 | Schwartz Aharon |
Director | Buy | 129,000 |
| 2024-09-23 | Naos Yaron |
Sr. VP, Operations | Award | 100,000 |
| 2024-09-23 | Rubin Eyal |
Chief Financial Officer | Award | 99,010 |
| 2024-04-01 | Bashan Dror |
Director, PRESIDENT AND CEO | Award | 263,960 |
| 2023-10-19 | Bashan Dror |
Director, PRESIDENT AND CEO | Buy | 16,129 |
| 2023-10-19 | Bashan Dror |
Director, PRESIDENT AND CEO | Buy | 48,387 |
| 2023-09-29 | Boudes Pol F |
Director | Award | 61,676 |
| 2023-09-29 | Schwartz Aharon |
Director | Award | 61,676 |
| 2023-09-29 | Melincoff Gwen A |
Director | Award | 61,676 |
| 2023-09-29 | Ben Zvi Shmuel |
Director | Award | 61,676 |
| 2023-09-29 | Bar-Shalev Amos |
Director | Award | 61,676 |
| 2023-09-14 | Forster Eliot |
Director | Award | 85,715 |
| 2023-09-14 | Forster Eliot |
Director | Other | 0 |
| 2023-08-15 | Rubin Eyal |
Chief Financial Officer | Award | 201,903 |
| 2023-08-15 | Naos Yaron |
Sr. VP, Operations | Award | 187,344 |
| 2023-08-15 | Hayon Yael |
VP, Research & Development | Award | 35,115 |
| 2023-08-15 | Hayon Yael |
VP, Research & Development | Award | 35,115 |
| 2023-08-15 | Bashan Dror |
Director, PRESIDENT AND CEO | Award | 800,000 |
| 2023-01-03 | Schwartz Aharon |
Director | Buy | 110,000 |
| 2022-09-07 | Boudes Pol F |
Director | Award | 50,000 |
| 2022-09-07 | Bashan Dror |
Director, PRESIDENT AND CEO | Award | 750,000 |
| 2022-09-07 | Ben Zvi Shmuel |
Director | Award | 10,000 |
| 2022-09-07 | Hayon Yael |
VP, Research & Development | Award | 250,000 |
| 2022-09-07 | Bar-Shalev Amos |
Director | Award | 50,000 |
| 2022-09-07 | Melincoff Gwen A |
Director | Award | 50,000 |
| 2022-09-07 | Schwartz Aharon |
Director | Award | 50,000 |
| 2022-09-07 | Rubin Eyal |
Chief Financial Officer | Award | 350,000 |
| 2022-09-07 | Bronfeld Zeev |
Director | Award | 100,000 |
| 2022-09-07 | Naos Yaron |
Sr. VP, Operations | Award | 340,000 |
Showing 1–50 of 71 transactions